These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5382524)

  • 61. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase.
    Hey C; Boucher JL; Vadon-Le Goff S; Ketterer G; Wessler I; Racké K
    Br J Pharmacol; 1997 Jun; 121(3):395-400. PubMed ID: 9179379
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Protection of the liver and liver therapy with Hepamerz].
    Heynen U
    Z Allgemeinmed; 1970 Jan; 46(2):87-8. PubMed ID: 5439291
    [No Abstract]   [Full Text] [Related]  

  • 63. [Controlled clinical study of the therapeutic activity of arginine thiazolidine carboxylate in patients with chronic toxic and postinfective hepatopathies].
    Salsano F; Ciancarelli MP
    Minerva Dietol Gastroenterol; 1979; 25(4):391-8. PubMed ID: 400006
    [No Abstract]   [Full Text] [Related]  

  • 64. [Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study].
    Henglein-Ottermann D
    Ther Ggw; 1976 Sep; 115(9):1504-18. PubMed ID: 968783
    [No Abstract]   [Full Text] [Related]  

  • 65. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver].
    Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A
    Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Clinical trial of injectable ampicillin in hepato-biliary diseases in particular].
    Fraisse H; Etaix JP
    Lyon Med; 1966 Jan; 215(5):271-7. PubMed ID: 5909728
    [No Abstract]   [Full Text] [Related]  

  • 67. [Clinical experience in the treatment of chronic liver diseases with Solcohepsyl extralysate].
    Arias Vallejo E
    Folia Clin Int (Barc); 1966 Sep; 16(9):404-15. PubMed ID: 5990974
    [No Abstract]   [Full Text] [Related]  

  • 68. Gastrectomized patients are in a state of chronic protein malnutrition analyses of 23 amino acids.
    Saito A; Noguchi Y; Yoshikawa T; Doi C; Fukuzawa K; Matsumoto A; Ito T; Tsuburaya A; Nagahara N
    Hepatogastroenterology; 2001; 48(38):585-9. PubMed ID: 11379360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term oral lysine supplementation in lysinuric protein intolerance.
    Tanner LM; Näntö-Salonen K; Niinikoski H; Huoponen K; Simell O
    Metabolism; 2007 Feb; 56(2):185-9. PubMed ID: 17224331
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Changes in the content of certain free amino acids in the blood serum in chronic liver disease under the influence of prednisolone therapy].
    Isakova ZS
    Ter Arkh; 1966 Oct; 38(10):80-4. PubMed ID: 5999185
    [No Abstract]   [Full Text] [Related]  

  • 71. Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects.
    Nagasaka H; Tsukahara H; Yorifuji T; Miida T; Murayama K; Tsuruoka T; Takatani T; Kanazawa M; Kobayashi K; Okano Y; Takayanagi M
    Metabolism; 2009 Mar; 58(3):278-82. PubMed ID: 19217439
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical evaluation of the activity of calcium-2,2'-disulfohexanoate in liver insufficiency].
    Romboli L; Leonardi R; Bertucci P; Fortunati P
    Clin Ter; 1978 Nov; 87(3):265-72. PubMed ID: 753574
    [No Abstract]   [Full Text] [Related]  

  • 73. [Treatment of chronic diseases of the liver parenchyma with thioctic acid].
    Dabski H; Brzeski Z
    Pol Tyg Lek; 1970 Jun; 25(24):899-901. PubMed ID: 4913117
    [No Abstract]   [Full Text] [Related]  

  • 74. [Biological and biochemical analysis of the action of Ornitaine on the diseased liver].
    Billiottet J
    Clinique (Paris); 1966 Jan; 60(615):67-70. PubMed ID: 4159874
    [No Abstract]   [Full Text] [Related]  

  • 75. [Clinical observation on the vasoconstrictive effect of POR 8 in vaginal surgery].
    Grcić R; Vukmirović K
    Srp Arh Celok Lek; 1969 May; 97(3):339-44. PubMed ID: 5199424
    [No Abstract]   [Full Text] [Related]  

  • 76. [Ureide succinate of 5 (4)-amino-4 (5) imidazolcarboxyamide, a new substance with hepato-regenerative and hepato-protective action. Preliminary clinical trials compared with an active standard reference].
    De Candia O; Fusi F; Bartolucci E
    Minerva Gastroenterol; 1973; 19(3):175-86. PubMed ID: 4766771
    [No Abstract]   [Full Text] [Related]  

  • 77. [Clinical and biological efficacy of an hepatic anticytolytic, Bo 714].
    Monges H; Salducci J; Deronzier C
    Therapeutique; 1969 Nov; 45(9):869-74. PubMed ID: 5365411
    [No Abstract]   [Full Text] [Related]  

  • 78. [Liver damage due to chlorpromazine and its treatment with arginine glucose-1-phosphate].
    Poggi E; Ferrari G
    Epatologia; 1971; 17(1):127-31. PubMed ID: 5147857
    [No Abstract]   [Full Text] [Related]  

  • 79. [Therapeutical analysis of a sorbitol plus fentropilium compound on various clinical forms of liver diseases].
    Ferraz WG
    Hospital (Rio J); 1967 May; 71(5):1403-12. PubMed ID: 5303472
    [No Abstract]   [Full Text] [Related]  

  • 80. [Ornithine and aspartic acid: catalizers of ureogenesis. Recent use in hepato-protective therapy].
    CEDRANGOLO F
    Riforma Med; 1962 Dec; 76():1453-6. PubMed ID: 14019581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.